IRI — Integrated Research Cashflow Statement
0.000.00%
- AU$75.95m
- AU$45.56m
- AU$83.29m
- 85
- 95
- 50
- 88
Annual cashflow statement for Integrated Research, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Changes in Working Capital | — | 0.626 | 0 | — | — |
Other Operating Cash Flow | |||||
Cash from Operating Activities | 24.2 | 21.1 | 16.9 | 13.8 | 13 |
Capital Expenditures | -15.2 | -12.2 | -11.8 | -7.79 | -0.048 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 0.992 | 1.44 | 2.05 | 1.13 | 2.32 |
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -14.2 | -10.8 | -9.75 | -6.66 | 2.27 |
Financing Cash Flow Items | -0.386 | -0.602 | -0.225 | -0.068 | -0.096 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -9.72 | -7.04 | -7.18 | -1.7 | -1.69 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 0.428 | 2.4 | 0.18 | 6.22 | 13.3 |